Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

Amino acid metabolism was the primary altered super pathway in DMD followed by carbohydrate metabolism and lipid metabolism. In contrast, BMD and LGMD 2A exhibited a more prominent alteration in lipid metabolism followed by amino acid metabolism. In SCAs, primarily lipid, amino acid, peptide, nucleotide, and xenobiotics pathways are affected. Our findings offer new insights into the variance of metabolite levels in MD and SCA, with substantial implications for pathology, drug development, therapeutic targets and clinical management. Intriguingly, this study identified two novel metabolites associated with SCA. This pilot cross-sectional study warrants further research involving larger groups of participants, to validate our findings.

Authors

Institutions

Publication Details

Journal
Frontiers in Molecular Neuroscience
Published
2025-01-10
DOI
https://doi.org/10.3389/fnmol.2024.1482999
Citations
2
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

Harry W.M. Steinbusch, Athula Dissanayake, K. Ranil D. de Silva, Ashwin Bhikaji Dalal et al.
2 citations
Frontiers in Molecular Neuroscience
Mitochondrial Function and Pathology
1.61
article

Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

Harry W.M. Steinbusch, Athula Dissanayake, K. Ranil D. de Silva, Ashwin Bhikaji Dalal, Harsha Gunasekara, Lakmal Gonawala, Chandra Mohan, Dhammika Amaratunga, Nalaka Wijekoon, Eric P. Hoffman, Yetrib Hathout, Darshana Sirisena, Pyara Ratnayake
article en
2 citations

Abstract

Amino acid metabolism was the primary altered super pathway in DMD followed by carbohydrate metabolism and lipid metabolism. In contrast, BMD and LGMD 2A exhibited a more prominent alteration in lipid metabolism followed by amino acid metabolism. In SCAs, primarily lipid, amino acid, peptide, nucleotide, and xenobiotics pathways are affected. Our findings offer new insights into the variance of metabolite levels in MD and SCA, with substantial implications for pathology, drug development, therapeutic targets and clinical management. Intriguingly, this study identified two novel metabolites associated with SCA. This pilot cross-sectional study warrants further research involving larger groups of participants, to validate our findings.

Frontiers in Molecular NeuroscienceVol. 17
Binghamton University (US), University of Sri Jayewardenepura (LK), Princeton University (US), Lady Ridgeway Hospital for Children (LK), Teaching Hospital Kandy (LK), Maastricht University (NL), Colombo North Teaching Hospital (LK), University of Houston (US), Centre for DNA Fingerprinting and Diagnostics (IN)
World Health Organization, Muscular Dystrophy Association, Aromatic Plant Research Center, International Brain Research Organization, University of Sri Jayewardenepura, International Society for Neurochemistry, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 20%
Mitochondrial Function and Pathology
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.